SOURCE: Gamma Pharmaceuticals, Inc.

October 05, 2010 08:00 ET

Gamma Pharmaceuticals Expands National Distribution Network by Over 2,000 Retail Outlets

LAS VEGAS, NV--(Marketwire - October 5, 2010) -  Gamma Pharmaceuticals, Inc. (PINKSHEETS: GMPM) Gamma Pharmaceuticals, Inc. ("Gamma" or the "Company") announced the expansion of its national distribution network via a comprehensive wholesale distribution agreement with a leading distributor based in Indiana. Under the terms of the agreement, the distributor will provide wholesale distribution for Gamma's Jugular Energy™ and Brilliant Choice™ product lines to approximately 2,000 retail outlets in selected territories. Purchase orders are being organized immediately from retailers for Gamma's groundbreaking Jugular Energy™ Gel products and Brilliant Choice™ brand. 

Gamma's CEO Peter Cunningham commented, "Our new partner is a leading distributor in several key markets and is an excellent fit with our distribution strategy." Mr. Cunningham continued, "Last week we announced the initial progress of our ramp-up and are pleased to add another key part to our comprehensive national distribution program. We will drive revenues from a variety of wholesale distributors and food, pharmacy, discount and convenience store retailers as we expand geographically, add additional products and sign-on additional distribution partners and retailers. Gamma is in the process of fulfilling additional purchase orders and pursuing retail channel opportunities nationwide."

About Gamma Pharmaceuticals, Inc.

Gamma Pharmaceuticals, Inc. ( is a marketing and product formulation company selling its own branded products through wholesalers and direct to retailers, both in the US and internationally. Gamma's core focus is the marketing and sale of vitamins and nutriceuticals, OTC pharmaceutical products and personal care products in the United States and Greater China. Branded nutritional supplements are sold under the trademarks Brilliant Choice™ children's nutritional supplements featuring a gummy immune booster product; SAVVY™ adult nutritional supplements featuring formulations especially designed for the health issues of seniors and active adults, Jugular Energy Products™ and high performance supplements featuring the call to action, "Go for the Jugular™," and high performance sports nutrition products under the "Holyfield's Choice™" brand jointly developed with boxing legend Evander Holyfield. Gamma's customer focus is on selling products in the Lifestyle of Health & Sustainability ("LOHAS") marketplace and in the Energy Supplement Market. A series of innovative marketing programs supports Gamma's product sales and retail partners.

At present Gamma's products are manufactured in North America, and today, distributed in the United States and have been distributed in Asia where the Company maintains a wholly owned subsidiary based in Hong Kong and a representative office in Beijing. Gamma's products utilize proprietary patent pending "Gel Delivery Technology®," designed to create innovative gel product forms that give consumers a more pleasant experience. Gel Delivery Technology® characteristics include rapid absorption, convenience and taste great. Market categories Gamma targets are growing as rapidly as 60% per year. Gamma has developed formulas and strategies for Metabolic Syndrome (pre diabetes), Stress Reduction, Cognition, Well being, Menopause Symptoms and Personal Care Products. Gamma also develops and manufactures house brands for major retailers. At this time, Gamma has a total of 43 SKUs and holds licenses for 9 SKUs in China.

Forward-Looking Statements: This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this Press Release regarding any impact the quotation of the Company's stock has on the Pink Sheets or the lack thereof on the OTCBB, and any other effects of the above are forward-looking statements. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. The Company cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

Contact Information